GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on June 2, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not indicate any new material risks.
Key Players & Entities
- GSK plc (company) — The company making the share purchase.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK plc.
- June 2, 2025 (date) — The date of the share purchase announcement.
FAQ
What was the specific number of GSK plc ordinary shares purchased?
The filing states that GSK plc has purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What was the total dollar amount spent on the share repurchase?
The filing does not disclose the total dollar amount of the share repurchase.
On what date were the shares purchased?
The filing indicates the 'Date of purchase:' but the specific date is not provided in the excerpt.
Who is GSK plc's corporate stockbroker for this transaction?
GSK plc is acting through its corporate stockbroker, Citigroup Global Markets Limited.
What is the par value of GSK plc's ordinary shares?
The ordinary shares are of 31¼ pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding GSK plc (GLAXF).